Patent details

EP1523335 Title: INJECTABLE DEPOT FORMULATION COMPRISING CRYSTALS OF ILOPERIDONE

Basic Information

Publication number:
EP1523335
PCT Application Number:
PCT/EP/2003/007619
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP037564556
PCT Publication Number:
WO/2004/006886
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INJECTABLE DEPOT FORMULATION COMPRISING CRYSTALS OF ILOPERIDONE
French Title of Invention:
PREPARATION EN DEPOT INJECTABLE COMPRENANT DES CRISTAUX D'ILOPERIDONE
German Title of Invention:
INJIZIERBARE DEPOTFORMULIERUNG ENTHALTEND ILOPERIDONKRYSTALLE
SPC Number:

Dates

Filing date:
14/07/2003
Grant date:
20/12/2006
EP Publication Date:
20/12/2006
PCT Publication Date:
22/01/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/04/2005
EP B1 Publication Date:
20/12/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/07/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/07/2003
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/12/2006
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
AHLHEIM Markus
Address:
Germany (DE)

2

Name:
WIECKHUSEN Dierk
Address:
Germany (DE)

3

Name:
GLAUSCH Alexandra
Address:
Germany (DE)

Priority

Priority Number:
0216416
Priority Date:
15/07/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 47/38;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/07/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages